Aspiriant LLC’s General Dynamics GD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Sell
4,364
-316
-7% -$112K 0.04% 129
2025
Q4
$1.58M Buy
4,680
+247
+6% +$84.2K 0.05% 131
2025
Q3
$1.51M Sell
4,433
-516
-10% -$163K 0.05% 117
2025
Q2
$1.44M Buy
4,949
+454
+10% +$125K 0.05% 122
2025
Q1
$1.23M Buy
4,495
+363
+9% +$94.3K 0.04% 128
2024
Q4
$1.09M Sell
4,132
-54
-1% -$15.5K 0.04% 136
2024
Q3
$1.27M Sell
4,186
-359
-8% -$106K 0.05% 127
2024
Q2
$1.32M Sell
4,545
-424
-9% -$124K 0.05% 122
2024
Q1
$1.4M Buy
4,969
+288
+6% +$77K 0.06% 121
2023
Q4
$1.22M Buy
4,681
+7
+0.1% +$1.71K 0.05% 129
2023
Q3
$1.03M Sell
4,674
-40
-0.8% -$8.85K 0.05% 129
2023
Q2
$1.01M Sell
4,714
-22
-0.5% -$4.75K 0.05% 131
2023
Q1
$1.08M Hold
4,736
0.06% 127
2022
Q4
$1.18M Buy
4,736
+91
+2% +$22.2K 0.06% 118
2022
Q3
$986K Buy
4,645
+538
+13% +$122K 0.05% 119
2022
Q2
$908K Sell
4,107
-1,576
-28% -$363K 0.04% 130
2022
Q1
$1.37M Sell
5,683
-11
-0.2% -$2.44K 0.08% 108
2021
Q4
$1.19M Buy
+5,694
New +$1.15M 0.06% 123

Other funds holding GD

Aspiriant LLC's GD Position: Q1 2026 in Review

Aspiriant LLC reduced its General Dynamics (GD) stake by 6.8% in Q1 2026, selling an estimated $112K and leaving 4,364 shares worth $1.5M. The position accounts for 0.04% of the portfolio, ranked #129.

Aspiriant LLC first reported a position in GD in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.58M in Q4 2025. 2,206 funds tracked by Wall St. Rank hold GD as of Q1 2026.

  • Aspiriant LLC held 4,364 shares of General Dynamics worth $1.5M as of Q1 2026.
  • Aspiriant LLC sold 316 General Dynamics shares in Q1 2026, an estimated $112K.
  • General Dynamics made up 0.04% of Aspiriant LLC's portfolio in Q1 2026, its #129 holding.
  • Aspiriant LLC first reported a position in General Dynamics in Q4 2021 and has held it in 18 quarters since.
  • Aspiriant LLC's General Dynamics position peaked at $1.58M in Q4 2025.
  • 2,206 funds tracked by Wall St. Rank held General Dynamics as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.